Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tobramycin-induced hypersensitivity reaction

J S Schretlen-Doherty1, W G Troutman

  • 1University of New Mexico College of Pharmacy, Presbyterian Hospital, Albuquerque, USA.

The Annals of Pharmacotherapy
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Position paper update: gastric lavage for gastrointestinal decontamination.

Clinical toxicology (Philadelphia, Pa.)·2013
Same author

Position paper update: ipecac syrup for gastrointestinal decontamination.

Clinical toxicology (Philadelphia, Pa.)·2013
Same author

Variability in the assessment of adverse events in a multicenter clinical trial.

Clinical therapeutics·2002
Same author

Minocycline-associated tooth staining.

The Annals of pharmacotherapy·1998
Same author

Evaluation of drug information in an Internet newsgroup.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·1997
Same author

Fatal poisoning among American Indian, Hispanic, and non-Hispanic white children in New Mexico, 1958 to 1982.

Ethnicity & disease·1991
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
Same journal

Modified vs Full Lead-in Dose Apixaban and Rivaroxaban for Treatment of Acute Venous Thromboembolism.

The Annals of pharmacotherapy·2026
Same journal

A Comparison of Phenobarbital Dosing Strategies for the Treatment of Alcohol Withdrawal Syndrome.

The Annals of pharmacotherapy·2026
See all related articles

Hypersensitivity reactions to tobramycin can occur in cystic fibrosis patients. Desensitization therapy, including nebulized tobramycin, may effectively manage these reactions and maintain treatment efficacy.

Area of Science:

  • Pharmacology
  • Pulmonology
  • Allergy and Immunology

Background:

  • Cystic fibrosis (CF) patients often require aggressive antibiotic therapy for pulmonary exacerbations.
  • Aminoglycosides, such as tobramycin, are crucial for treating Pseudomonas aeruginosa infections in CF.
  • Hypersensitivity reactions to antibiotics can complicate treatment regimens.

Observation:

  • A case report details an 18-year-old male with CF experiencing a hypersensitivity reaction to intravenous tobramycin.
  • The reaction, including shaking, arm blanching, urticaria, and pruritus, occurred shortly after tobramycin administration.
  • The patient had a history of a similar reaction to intravenous tobramycin four years prior, necessitating desensitization.

Findings:

  • Despite prior successful desensitization with nebulized tobramycin, the patient developed a hypersensitivity reaction upon restarting intravenous administration.

Related Experiment Videos

  • Hypersensitivity to one aminoglycoside often implies cross-reactivity with others in the same class.
  • Desensitization can be a viable strategy for continuing essential aminoglycoside therapy.

    • Implications:

    • This case highlights the potential for hypersensitivity reactions even after successful desensitization protocols.
    • Maintaining effective desensitization may require careful monitoring and adherence to treatment schedules, including nebulized tobramycin.
    • Desensitization offers an alternative to discontinuing critical antibiotic therapy in CF patients with hypersensitivity concerns.